2010 CPT Annual Report_Annual Report JRL

8/8/2019 2010 CPT Annual Report_Annual Report JRL

1/14

Cancer Prevention andTreatment Fund

2009 Annual Report


2/14

The mission of the Cancer Prevention and Treatment Fund is preventing cancer,

improving screening for all types of cancer, and helping patients receive the

best possible treatments.

OUR MISSION


3/14

In 2009, the Cancer Prevention andTreatment Fund had a major impact onpublic information, public debate, andpublic policy. Our efforts were particularlyeffective because of our strong focus onhelping patients and their families,improving public health, and our workwith Congress and the White House.

We helped people across thecountry reduce their risk of cancer andchoose the safest and most effectivetreatments.

Through our online cancer hotline,we helped patients decide which screeningtests and treatments were best for them,and which were likely to do more harmthan good.

We urged the FDA to approve anew vaccine to prevent cervical cancer andto require long-term studies of safety andeffectiveness for all vaccines so that parentscould make well-informed decisions fortheir childrens health.

We co-sponsored an internationalconference and Senate meeting on thepotential health risks of cell phones, andworked to reduce radiation exposure fromcell phones for children and adults.

We persuaded the federalgovernment to improve the publics accessto information about the safety andeffectiveness of specific medications,vaccines, and medical devices, and tostrengthen the safeguards that protectpatients and consumers.

We testified numerous times beforethe FDA Science Board and AdvisoryCommittees, urging them to remove unsafebaby bottles and food containers from oursupermarket shelves and urging them not toapprove an ovarian cancer drug thatreduced the quality of life and wasineffective at prolonging life.

We expanded our public educationefforts to improve the safety of childrenstoys and reduce potentially toxicenvironmental exposures that affect health.

We recognized congressionalchampions with our new Health PolicyHeroes Awards.

Whether we were explaining well-established and complicated scientificinformation to families and the medicalcommunity, or making sense ofcontroversial new research on new vaccines,old medications, or toxic chemicals in toys,we scrutinized research and provideduseful, understandable, and unbiasedanalyses to the media, patients, consumers,and policy makers. Our research andadvocacy work continues to represent theinterests and needs of ordinary men,women, and children, who are often left outof policy debates and life-saving publichealth decisions. As always, we willcontinue to advocate for the public onmatters that are crucial to the health andwell-being of adults and childrennationwide .

Diana Zuckerman, PhD

MESSAGE FROM THE PRESIDENT

P h o t o b y T . J .P o pk i n


4/14


5/14

Force, however, that there is insufficientevidence to recommend for or against PSAscreening for men under 75, and werecommend against screening for mostmen over 75.

Which Diagnostic Tests andTreatments are Best?

Every year, the Food and Drug Administration (FDA) reviews thousandsof new medical devices and allows themto be soldwithout first requiring clinical trials. As long as the products areconsidered substantially equivalent toothers on the market, a loose definitionthat does not require that they be madeof the same material or use a similarmechanism of action, they can be sold inthe U.S. Its not surprising, therefore,that many of these devices are laterrecalled because they are found to bedangerous. In addition, the vast majority

of prescription drugs and implanteddevices are approved on the basis ofshort-term safety and may not be provensafe for long-term use. We are working to improve these policies to preventproducts meant to help us from harming us.

New FDA Safeguards

When the FDA Advancement Act of 2007became law, we succeeded in including

new safeguards and increased resources tostrengthen the safety of prescription drugsand medical devices. For example,patients and doctors now have free accessto results of clinical trials, so thatcompanies cant hide information that isunfavorable to their products. Thelegislation also required the GovernmentAccountability Office (GAO) to examinethe process that allowed substantiallyequivalent devices to be sold, evenwithout clinical trials or proof of safety.

Now were working to make sure the FDAfollows through on much-needed changesto improve the safety and effectiveness ofall medical products.

Meetings with New FDACommissioner

The GAO report, released in January 2009,supported many of the criticisms we hadmade in previous years. NRC presidentDr. Diana Zuckerman was invited to meetwith the Obama Administrations newFDA Commissioner, Dr. MargaretHamburg, at several small meetings in2009 to discuss our concerns aboutmedical devices and prescriptionmedications. As a result of our work,change is coming to the FDA. There isnow a new director of the FDAs Centerfor Medical Devices and RadiologicalHealth who is much more concernedabout public health and a new study by

the Institute of Medicine that willrecommend improvements to the FDAreview process for medical devices.

Preventing Cancer

Were Spreading the Word:Radiation from Cell Phones MayCause Brain Cancer

You love your cell phone, but is it a hazardto your health? Approximately 1 billion

people use cell phones worldwide, withover 110 million Americans using cellphones daily. These devices depend onradio waves that were assumed to be safe,but new research tells us otherwise. Thedirector of the University of PittsburghCancer Institute, Dr. Ronald Herberman,warned his staff in July 2008 that the risksfrom cell phone radiation raise concerns.He advised that rather than wait fordefinitive studies, we should curb our cellphone use immediately. Meanwhile,

studies indicated that using a cell phonefor ten or more years increases the risk ofbeing diagnosed with a brain tumor on theside of the head where the cell phone userholds the phone.

In September 2009, we helped bringtogether scientists from around the worldfor a national conference on cell phones inWashington, D.C. and organized a Senatemeeting on cell phones and health. Weagree with the experts convened in thecapital that since the extensive use of cellphones has increased dramatically andsince cancers usually take at least 10-20years to develop, it will be years beforeresearch can conclude whether cell phones

cause cancer or not. Meanwhile, well-designed studies indicate that theradiation from cell phones can damageDNA, suppress the immune system, andincrease the risk of tumors, includingcancer. Children are at higher risk thanadults because of their thinner and smallerskulls, which absorb more radiation.

Precautions You Can Take

Scientists recognize that most people are

not going to stop using cell phones. Hereare their recommendations on how tolower your exposure and your risks:

Limit the number and length of yourcalls.

Use hands-free devices, put the cellon speaker phone, or hold the phoneaway from your ear.

When speaking on your cell phone,alternate sides.

Limit your cell phone use in rural

PROGRAM AND POLICY HIGHLIGHTS

03

Im a cancer survivor myself and love to donate to the cause as much as possible. Keep up the good work and thank you. Its your research that has saved my life.

--Shane King, Wichita, Kansas


6/14

areas or anywhere reception is poor. Moreradiation is emitted when you are fartherfrom a cell phone tower.

Text message instead of talking(never while driving!)

Go over these guidelines with yourchildren and limit their cell phone use.

Avoid keeping your cell phone inyour pocket or close to your body while itis on.

We Want You to Know: Radiationfrom CT Scans Increases Cancer Risk

People in the U.S. are exposed to aboutsix times more radiation from medicaltechnology today than in the 1980s.Computed Tomography (CT scanning, orCAT scan) is a wonderful tool fordetecting tumors, determining iftreatment is shrinking those tumors,finding blockages in the hearts arteries,and other important diagnostic strategies.

About 1 in 5 people get a CT scan everyyear. Unfortunately, CT scans use largedoses of radiation and have the potentialto harm patients even as they help them.

Some doctors have recently been using CTscans to detect blockages in the heartsarteries that can cause heart attacks.However, an average heart CT scanexposes a patient to as much radiation asat least 30sometimes as much radiationas 400chest x-rays. If this test is widely

used, we could see many new cases ofcancer from increased exposure toradiation.

Is it worth the risk? Although there is abenefit to early diagnosis of heart disease,the American Heart Association, AmericanCollege of Cardiology, and the UnitedStates Preventive Services Task Force donot recommend the use of heart CT scansfor any patientswhether at low or highrisk of heart disease. The reason is that the

radiation from CT scans could causecancer, and that risk is greater than thelikely benefits. A recent study estimatedthat one heart CT scan for 50 millionAmericans could cause 2,700-37,000 newcancer cases, depending on the dose ofradiation. The number of new cancer casescould be even higher if individuals werescreened more than once in their lifetime.

Even when CT scans are necessary,radiation can be a problem.Unfortunately, there is no establishedguideline for how much radiation should beused for each type of CT scan, with CTscans in some hospitals delivering as muchas 13 times as much radiation as otherhospitals. On October 8, 2009, the FDAannounced that it was notifying healthcareprofessionals that 206 patients who werebeing tested for stroke received CTradiation doses to the brain that weremuch higher than expected at the

nationally respected Cedars Sinai Hospitalin Los Angeles. Since then, the FDA hasdiscovered that CT scans given to strokevictims in at least four hospitals exposedmore than 300 patients to excessively highlevels of radiation. We are working withexperts across the country to reduce theserisks by improving CT scan machines andtraining, and educating doctors andpatients to avoid unnecessary CT scans.

We Helped to Ban Dangerous

Chemicals in Plastics

When we first started to examine researchon plastics that affect hormones, mostAmericans didnt know what bisphenol-A or phthalates wereor how topronounce them. We explained to policymakers and journalists what the researchshowed and why we were concerned thatthese chemicals interfere with our bodyshormones and may cause cancer andother serious diseases. As a result, these

chemicals are banned from manycommon products today, which reducesthe risk for our children.

Bisphenol-A (BPA) was widely used inplastic sports water bottles and babybottles until our work helped persuadecompanies to stop using it. BPA is stillwidely used to line almost all food andbeverage cans in the U.S., however.We think of plastic as being solid, but BPAleaches out of plastic containers intoliquids and foods. The Centers for DiseaseControl and Prevention found BPA in thebodies of more than 93 percent ofAmericans, and the highest daily intakesare in infants and children.

BPA mimics and interferes with estrogen,which is important in reproduction anddevelopment. Until recently, many plasticbaby bottles contained BPA. BPA isespecially likely to get into liquids from aplastic container when heated, such as

when one warms a baby bottle. Scientistsare concerned about how BPA affects thebehavior of young children, and whether itcan affect the prostate, breasts, and brain.For example, BPA could potentiallyincrease the likelihood of early puberty ingirls and breast cancer in women, or therisk of prostate cancer in men. Studieshave also now found that adults with moreBPA in their urine were more than twice aslikely to have heart disease or diabetesthan those with the lowest levels,


04

Dr. Zuckerman's pitch as it pertained to various health related issues were absolutely phenomenal. Her ability to touch on very important issues of health in a small amount of time was not only informative, but contributed immeasurably to the success of our kickoff.

Sammy Payne, Deputy Chief of Staff G-8, United States Army


7/14


8/14

years, and often much sooner. In 2008,approximately 11,000 women in the U.S.were diagnosed with cervical cancer, andan estimated 3,800 women died fromcervical cancer.

Gardasil is the most expensive vaccineever recommended for school-agechildren, and an important unansweredquestion is how long it lasts. The FDA didnot require long-term studies of Gardasil,and we have demanded that they finallydo so. Meanwhile, it is not known if abooster shot is needed, and if so when.That means that girls and women whoreceived Gardasil several years ago mayno longer be protected against cervicalcancer. In comparison, the FDA requiredlonger-term studies of the HPV vaccineCervarix, and the early evidence suggeststhat Cervarix will last longer.

Like any public health intervention, a

vaccine's risks must be weighed against itsbenefits. This is why it is so important todetermine the vaccine's efficacy and howlong it lasts. If the vaccine is offeringminimal protection or instilling a falsesense of immunity, almost any risk oradverse reaction becomes unacceptable.

Were Spreading the Word: ObesityIncreases the Risk of Several Typesof Cancer

Everyone knows about the obesityepidemic and its impact on diabetes, butobesity causes other health risks as well.Girls and boys are starting puberty asearly as 8 years old, and one reason is thatobesity affects hormonesand that couldalso increase the risk of breast cancer,prostate cancer, colorectal cancer, andsome other cancers. The risk of obesitymay be increased by BPA, phthalates, andother chemicals that influence hormonesand fat cells.

In addition to our activities regarding BPAand phthalates described in the previoussection, the Cancer Prevention andTreatment Fund scrutinized new researchto determine other potential causes ofweight gain that could increase the risk ofcancer.

Obesity is caused by eating more caloriesthan you burn up from physical activity,but some popular prescription medicationsdrastically increase appetite and obesity.Some of the drugs that are especially likelyto cause obesity are atypicalantipsychotics, which are taken by morethan 30 million Americans each year. Inthe spring, summer, and fall of 2009, ourPresident Dr. Diana Zuckerman testifiedbefore FDA Advisory Committees to pointout the risks of atypical antipsychoticssuch as Seroquel, Zyprexa, Risperdal,Geodon, and Abilify. These drugs wereoriginally approved for the treatment of

delusions, hallucinations, and other formsof psychosis that are symptoms ofschizophrenia and manic depression.However, most of the 30 millionprescriptions filled each year in the U.S.are for other symptoms such asdepression, anxiety, insomnia, or behaviorproblems typical of ADHD or AlzheimersDisease. These drugs have serious risks,including sudden death, but the mostcommon risk is rapid weight gain, whichincreases the risk of diabetes and also

increases the risks of breast cancer,prostate cancer, and other cancers. Withmore than 35 million prescriptions filledeach year, the impact of these drugs oncancer rates could be substantial.

Congressional Testimony,Briefings, College Lectures,and Speeches

The Cancer Prevention and TreatmentFund provides policymakers, health

professionals, and other opinion leaderswith an unbiased explanation of scientificdata so that they can make educateddecisions that affect everyone in ournation. Our research and advocacy workrepresents the interests of ordinary womenand families, who are often left out ofpolicy debates. We educate leaders in ournations capital and across the country.

Dr. Zuckerman testified about BPAas a potential carcinogen at the DietaryGuidelines Advisory Committee meetingin January 2009, and before the FDAScience Board three times in 2009. TheCancer Prevention and Treatment Fundalso urged Members of Congress to passlegislation that would remove BPA fromfood and beverage containers.

The Cancer Prevention andTreatment Fund organized and hosted apresentation and discussion for consumeradvocates on Preventing Cancer & Birth

Defects , featuring Dr. Rich Purdy as guestspeaker, in February 2009. Dr. Zuckerman and Government

Relations Manger Paul Brown activelyparticipated in a national meeting toimprove medication adherence, sponsoredby the National Consumer League and theAgency for Healthcare Research andQuality (AHRQ) in February 2009.

Dr. Zuckerman was an invitedspeaker at an Institute of Medicinemeeting on future needs to improve

women's health in February 2009, whereshe focused on the need for moreinformation on racial and ethnicdifferences in medication effectiveness ,so that all patients could get the safest andmost effective treatments.

Dr. Zuckerman testified at an FDARisk Communication AdvisoryCommittee meeting in February 2009,urging the FDA to develop patientbooklets and medication guides that areeasier to understand.


06

Hopefully, every woman finds her way to your Web site. Your article has helped me arm myself with

information I will need to select the right surgeon.

Annamaria Picollo, Prospect, Oregon


9/14

Dr. Zuckerman testified aboutGardasil at a U.S. Health and HumanServices Vaccine Safety Working Groupmeeting in March 2009, emphasizing theneed for better long-term informationabout safety and effectiveness.

Dr. Zuckerman and GovernmentRelations Manager Paul Brown met withthe Consumer Product SafetyCommission staff to discuss the need toquickly remove phthalates from allchildrens products in March 2009.

The Cancer Prevention andTreatment Fund organized and hosted aCapitol Hill briefing on BPA featuringpresentations by Dr. Zuckerman andSarah A. Vogel, PhD, Program Officer, Johnson Family Foundation in April 2009.

Dr. Zuckerman met with senior staffof the AHRQ to discuss concerns aboutlong-term safety and effectiveness ofcancer vaccines and atypicalantipsychotics in April 2009.

Dr. Zuckerman was an invitedspeaker on the medical devices clearanceprocess at the Food and Drug LawInstitute Conference in April 2009.

Dr. Zuckerman testified oncomparative effectiveness research at aHealth and Human Services meeting inApril 2009.

Dr. Zuckerman testified on HPVvaccines at a Washington, D.C. Healthcommittee hearing in April 2009.

Dr. Zuckerman testified at FDA

Advisory Committee meetings on thehealth risks and cancer implications ofatypical antipsychotic medication in April2009, June 2009, and December 2009.

Meredith van Tyne testified for theCancer Prevention and Treatment staffabout the terrible side effects and lack ofclear benefit compared to other drugs of anew ovarian cancer drug at an FDAOncologic Drugs Advisory Committeemeeting in July 2009. The FDA agreed andthe drug was not approved.

Dr. Zuckerman testified at an FDAHuman Papillomavirus VaccineCommittee Meeting regarding the need forlong-term studies of effectiveness againstcancer in September 2009.

The Cancer Prevention andTreatment Fund helped organize aconference and Capitol Hill meeting oncell phones and brain cancer inWashington, D.C. in September 2009, andDr. Zuckerman was an invited speakerand workshop leader.

Dr. Zuckerman gave a guest lectureon cancer prevention at a health policycourse taught by Professor ElaineAnderson at the University of Maryland,College Park in November 2009.

07


You are a champion of many and I appreciate all you do.

Jackie Lombardo, Charlottesville, Virginia


10/14

To help give patients the information theyneed to get the best possible treatment forbreast cancer, we distributed free copies ofour booklet Surgery Choices for Women withEarly-Stage Breast Cancer (and the Spanishversion Las Primeras Etapas del Cancer deSeno) co-authored by our staff and stafffrom the National Institutes of Health, theNational Cancer Institute, and the Agencyfor Healthcare Research and Quality.These were distributed to MarylandsPrince Georges County HealthDepartment as part of its education andcounseling program, to the WashingtonCancer Institute, to the Capital Breast CareCenter in Washington, D.C., and to cancercenters and Komen affiliates across thecountry.

Our staff actively participated in meetingsof the D.C. Cancer Consortium, anassociation of all Washington, D.C. cancergroups and service providers. We offered

free technical assistance throughout theyear and disseminated information oncancer prevention and treatment at theCancer Survivor Jubilee in Washington,D.C.

On the Internet

Our new web site,www.stopcancerfund.org , began as part ofthe National Research Center for Women

and Families web site and became anindependent web site in 2009.

Coalition Building and Events

The Cancer Prevention and TreatmentFund and the National Research Center forWomen and Families has a primary role incoordinating the Patient, Consumer, andPublic Health Coalition, which includeswell-respected nonprofit organizationssuch as Consumers Union, the Union ofConcerned Scientists, the NationalWomens Health Network, Center forMedical Consumers, the NationalConsumer League, Title II CommunityAIDS Action Network, the GovernmentAccountability Project, Our BodiesOurselves, Breast Cancer Action,WoodyMatters, and U.S. PIRG. We hostednumerous coalition meetings, strategysessions, and nationwide efforts to helpconsumers understand new health

information in 2009.

Friday Luncheon Series

On selected Fridays throughout the year,the Cancer Prevention and TreatmentFund hosts a luncheon devoted to thelatest cancer prevention and treatmentstrategies issues. We invite medicalexperts to provide objective and usefulinformation. The luncheons are free andopen to the public.

Held at the conference room of theWashington offices of Reed Smith, theluncheons provide great speakers andfoster topical discussions.

Lunches in 2009 included:

HPV Vaccine: The Fact behind theHype, held on March 13, 2009, featuredCancer Prevention and Treatment FundPresident Dr. Diana Zuckerman and Dr.

Susan Wood, professor at GeorgeWashington University and Former

Director of the FDAs Office for WomensHealth.

How Does Body Image AffectHealth? an annual lunch on body imageand health for interns, held July 28, 2009.The lunch featured Cancer Prevention andTreatment Fund President Dr. DianaZuckerman and Lesley Fair of the FederalTrade Commission.

Health Policy Heroes AwardsLuncheon

In May 2009, we honored twoCongressional champions of cancertreatment and other health issues. Theawards event took place at the CosmosClub of Washington, D.C.

Rep. Rosa DeLauro (D-Connecticut) amember of Congress since 1991, is one ofCongress' most effective champions toimprove the health and safety of allAmericans. In 2009, she introduced theFood Safety Modernization Act to protectour nation's food supply. A cancersurvivor, she has successfully increasedfunding for breast and cervical cancerscreenings and research.

COMMUNITY OUTREACH AND EDUCATION

08

I am immensely grateful to you and Dr. Zuckerman for your thorough, succinct and clear response to my query -- and for providing it so very promptly.

--Ernest Herman, New York, NY

P h o t o b y Gw enL ewi s
http://www.stopcancerfund.org/http://www.stopcancerfund.org/


11/14

09


Senator Charles Grassley (R-Iowa) is theSenates most outspoken advocate onbehalf of safeguards to ensure the safetyand effectiveness of all medical products.Sen. Grassley is the ranking Republican onthe Finance Committee, which isresponsible for Medicare and Medicaid.His willingness to challenge the FDA hassaved the lives of adults and children byhelping remove unsafe medical productsfrom the market. Sen. Grassley, whosewife is a cancer survivor, commended theCancer Prevention and Treatment Fund onits work, saying, Your group helps peopleget unbiased information of what isneeded when it is most needed. Thats aninvaluable service, and yet just a small partof what you do.

Internships

The Cancer Prevention and TreatmentFund was assisted by impressive interns in2009, including: Krystle Seu, a student atthe University of Maryland; MaushamiDeSoto, a graduate student at theUniversity of Maryland; Heidi Mallis, agraduate student of public health atTulane University; and Julie Bromberg of Johns Hopkins Bloomberg School ofPublic Health.

In addition, two graduate studentsreceived internships named for MarcyGross and Joy Simonson, whose idealismand accomplishments have inspired ourwork.

Marcy Gross Internship

Marcy Gross was a nationally respectedadvocate for women's health who servedas a senior adviser at the U.S. Departmentof Health and Human Services. Ms. Grosshelped build the foundation for federalpolicies regarding sexual assault and other

women's health issues, and co-authored areport that became the basis of the federalHealthy Start Program, aimed at reducinginfant mortality and promoting health carefor children. After retiring from the federalgovernment in 2002, Marcy helpedorganizations dedicated to womens healthand safety. She was a strong voice forresearch-based medical treatment, andworked closely with us to improve thequality of care for breast cancer patients.

Meredith Van Tine , our Marcy GrossIntern for the summer of 2009, was in herfinal year at the University of VirginiasSchool of Law. She is preparing for acareer in womens health advocacy and

her goal is to focus on public policy, publiceducation, and research on health issuesthat affect women differently than men,including domestic violence.

In addition to being a law student,Meredith volunteers at the local SexualAssault Resource Agency at theCharlottesville FOCUS Womens ResourceCenter, and at Womens Health Virginia.

During her internship with NRC, Meredithresearched and wrote articles on a range ofhealth issues; attended Hill briefings onthe Violence Against Women Act;participated in womens healthcarecoalition meetings on healthcare reform;helped organize our annual internluncheon, and testified before the FDA onthe unfavorable risk-benefit ratio of a drugfor ovarian cancer.

Years ago, the Center directly affected my

life in a positive way by providing mewith important health information, saidMeredith. Now, thanks to the generosityof Marcy Gross family and friends I havefinally been able to return that favor byworking to further the Centers wonderfulmission.

Thank you so much for your rigorous attention to and proactive dissemination of informed analysis about these issues. Im sure many women appreciate having you as an advocate.

Shari Graydon, Author of In Your Face: The Culture of Beauty and You

P h o t o b y

Gw enL ewi s


12/14

Joy Simonson Internship

Joy Simonson was our National AdvisoryBoard member, Foremother honoree, andfriend, who passed away in June 2007 atthe age of 88. Joy was well known in thewomen's community as an activist andadvocate into her 70's and 80s. However,that was just the latest in a long list ofaccomplishments, starting when shemoved to Washington, D.C. in the 1940's towork for the War Manpower Commission,

and then to Egypt and Yugoslaviaimmediately after World War II to workfor the U.N. To honor and continue theremarkable contributions that Ms.Simonson made, the internship will focuson health issues for midlife and olderwomen.

Stephanie Portes-Antoine was our JoySimonson Intern for the summer of 2009.A Martin Luther King scholar as anundergraduate, Stephanie holds a Masters

in Public Health from Boston Universityand is now a second year medical studentat Boston University School of Medicine.Stephanie is keenly interested in healthdisparities, particularly racial/ethnic,gender, and socioeconomic. As part of herpublic health school practicum, sheworked on a reproductive health project inHaiti. Stephanie is the first intern to cometo us through the American MedicalAssociations Government RelationsInternship Program.

As our intern, Stephanie synthesizedresearch information on treatments forovarian cancer; attended Hill briefings onissues such as the efficacy of the HPVvaccine; participated in womens healthcare coalition meetings on the health carereform debate; and testified before theFDA on the potential risks of prescriptiondrugs used by children. She also analyzeddifferences in drug response amongAfrican American and Caucasian womensuffering from breast, cervical, and ovariancancer.

My experience this summer was amazing,and there is no doubt in my mind that Iwill carry what I learned this summer, notonly throughout my remaining academiccareer, but into my life as a futurephysician, Stephanie said.

In 2009, the media turned to the CancerPrevention & Treatment Fund for timelycancer-related health and medicalinformation from a credible source. Weresponded to frequent requests fromreporters and producers across the countryfor information, comments and interviews.The following is just a small sample of ourcoverage in 2009:

11/20/09, Rodale.com, The NewMammogram Guidelines: What YouShould Know

11/15/09, Leah Fabel, The WashingtonExaminer , The Inside View: DianaZuckerman

2/9/09, Brandel France de Bravo,Washington Post Letter to the Editor,Better Lullaby for Baby

10/31/09, Diana Zuckerman, Washington

Post Letter to the Editor, Breast CancerReport has the Wrong Focus

9/10/09, Philadelphia Enquirer , FDAadvisers back Glaxos drug for cervicalcancer

7/22/09, Associated Press, FDA:Electronic cigarettes contain toxicchemicals

9/4/09, Associated Press,Glaxos cancer

vaccine inches toward approval

9/9/09, Associated Press, FDA saysGlaxo vaccine to prevent cervical cancer issafe, effective

7/12/09, Buffalo News, Vaccine debateshifts to boys


10

MEDIA & COMMUNICATION


13/14

The Cancer Prevention and Treatment Fund is a programof the National Research Center for Women & Families.NRCs Boards are listed below.

BOARD OF DIRECTORS

George Thomas Beall, Managing DirectorGlobal Social Marketing Practice, Ogilvy Public

Relations Worldwide

Wendy Braund, MD, MPH, MSEdOffice of Disease Prevention and Health Promotion,

U. S. Department of Health and Human Services

Arthur L. Caplan, PhDDirector, Center for Bioethics

University of Pennsylvania School of Medicine

Ben Gitterman, MDAssociate Professor of Pediatrics and Public Health

Childrens National Medical Center

Mary G. Hager, MA, Writer

Nancy Hardt, MDProfessor and Associate Dean

University of Florida College of Medicine

Judith L. Harris, JDPartner, Reed Smith

Alan Mendelson, LLDAxion Venture Partners

Sharon Scribner PearceDirector of Public Policy, Girl Scouts of the USA

Omega Logan Silva, MDFormer President, American Medical Womens

Association

Susan F. Wood, PhDGeorge Washington University

Diana Zuckerman, PhD, President, National ResearchCenter for Women & Families

NATIONAL ADVISORY BOARD

The Honorable Rosa DeLauro (CT)

Mark Frankel, PhD, AAAS

Pat Hendel, Commissions for Women

Phyllis Katz, PhDInstitute for Research on Social Problems

Sally Kenney, PhDUniv. of Minnesota Center for Women & Public

Policy

Rebecca Klemm, PhDKlemm Analysis Group

Irene S. Levine, PhDNYU School of Medicine

Lisa Lopez, JD, Haemonetics

Mary McDonoughActress and Director

Shari Miles, PhD, American PsychologicalAssociation

The Honorable Olympia Snowe (ME)

Judy WoodruffThe NewsHour with Jim Lehrer


14/14

DONORS

Presidents CircleGeorge Thomas Beall

Arthur CaplanNancy Hardt

Catherine JoyceAlan Mendelson

Susan WoodAnne & Leo Zuckerman

Diana Zuckerman

Leadership CircleVernon BanfieldWendy Braund

Colette BroussardGwendolyn Champ

Diedre GilmerBen GittermanKaren GriffinGilbert GroveMary Hager

Katherine HailePeter Hart

Cynthia LundyLarry MayfieldKimberly MilesMary MitchellKatedra NixonGeorge Roarx

Omega Logan SilvaRonald Ulrigg

Joyce WahoskiBeth Walton

Veronica WilliamsAvery Wills

Circle of FriendsLouvenia Anderson

Robert BarnsbyArnita ColbertDonald DemasGeorge DudleyEmma Edwards

Pat ErvinMark GoodingMyrtle Hastie

Alan Ho Jose Johnson

Rebecca KlemmRobin KnightMelida LakeIrene Levine

Modes McGeeLeslie Perry-DowdellMiranda Queen John Roderick

Joanne Ruggeri Joan Spencer

Mary StackHoward Swigget

Joseph TaylorGeraldine Thomas Janice Williams

Roosevelt Williams, Sr.

In memory of Ros BranniganSusan CoulterMathea FalcoMary Kassler

Colleen Tootell

In memory of Marcy GrossPhyllis Zuckerman

In honor of Renee Harris Judith Harris

Generous Combined FederalCampaign Supporters

Craig AdamsFaye Allen

Terry AmstutzPamela Anderson

Susan Anima Jerry Bailey

T. BarclayMatthew Bennett

Loretta BirkLee Brinker

Latasha BriscoeVeta Brooks

Latasha BrownGlenn Butts

Cerena CabreraLacey Carver

William ChatfieldEnedina Chavez

Miguel ContrerasPaula Counts

James CrawfordGirolima DAmore

Charles DanielsRicardo De LunaRobert Dinerstein

Trey DreherLakeishia Dubose

Virgil DudleyVeronica Dunn-Deprehs

Sabrina EarleyWilliam Farichild

Mark FrankelBrandon Frazier

Kevin FurtickDonnice GeorgeRufus Gholson

Jamie GilGladdys Glover

Jonathan GomezCharles Graham, Jr.

Katherine Grobe Jennifer Gunter

Dale HarrisSherita HarrisApril Harvey

Kerry HendersonCynthia Herbert

Becky HurleyNikita IrvineTina Jackson

Roderick John

Percy JohnsonSherrie Johnson

Whitney KennedyZackery Kohon

Felicia LakeSteven Lambrecht

Tena LarneySusan Lawson

Tania Le

Geneva LemonsCharles LewisTwylla Lucas

Bernard MacPhersonCarlindean Madison

Biancha Martinez Jesus Martinez, III

Effie MatthewsBambi Mcelroy Jerry Michalak

Ruby MooreLoretta MorehouseMichael Mountain

Joanna MyersBibiana Noriega

Elizabeth PaganStacy Palmer-HillSharon PittmanKathryn Pleskin

Antonello PunturieriRoger RenfroDavid ReyesNicholas Rice

Alison RobbinsCherisse Roundtree

Eric SandersLoretta ShellsKayce SmallsDiane Smith

Patricia SmithSherrod SmithLoretta SolleyMonet StancilValerie StilesSheila Sturgis

Tonya SullivanMarian Szymborski

David TeallClark Thomas

Deborah TidwellMaria TorresRoger Torres

Blandino VillanuevaKimberly WashingtonLaToya Washington

Stephanie WhiteBrenda Williams

Chase WilliamsonKaren WinsteadRonnie WrightDaniel Young

Documents

2010 CPT Annual Report_Annual Report JRL